Clinical Risk Prediction Tools for Prostate Cancer: TNM to CAPRA—Should Risk Be Redefined?
Leapman M, Cooperberg M. Clinical Risk Prediction Tools for Prostate Cancer: TNM to CAPRA—Should Risk Be Redefined? 2016, 33-52. DOI: 10.1007/978-3-319-21485-6_3.Peer-Reviewed Original ResearchPrimary androgen deprivation therapyClinical risk prediction toolsUCSF-CAPRA scoreAndrogen deprivation therapyRisk stratification toolPretreatment clinical variablesRisk prediction toolsProstate cancer biologyProstate Cancer Risk PredictionCancer risk predictionAdvanced diseaseDeprivation therapyReliable risk estimationClinical characteristicsStratification toolClinical stageClinical variablesGleason scoreOutcomes warrantsRisk groupingPostsurgical settingProstate cancerInternational cohortClinical prognosticationNovel biomarkers
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply